{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Caguas",
      "state": "PR",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "78074",
      "recalling_firm": "Llorens Pharmaceutical Corp.",
      "address_1": "Carr. #1 Km 34.3",
      "address_2": "N/A",
      "postal_code": "00725",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Puerto Rico",
      "recall_number": "D-0081-2018",
      "product_description": "Urin D/S Tablets Methenamine 81.6 mg, Sodium Biphosphate 40.8 mg, Phenyl Salicylate 36.2 mg, Methylene Blue 10.8 mg, Hyoscyamine Sulfate 0.12 mg, Rx Only, 100-count bottle, Manufactured For: Llorens Pharmaceutical Corp., International Division, Miami, FL 33166. NDC: 54859-701-10",
      "product_quantity": "19232 bottles",
      "reason_for_recall": "Superpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets.",
      "recall_initiation_date": "20170905",
      "center_classification_date": "20171115",
      "termination_date": "20190403",
      "report_date": "20171122",
      "code_info": "Lots: 22811601, 22811602, Exp. 05/18; 202U1601 Exp. 11/18"
    }
  ]
}